Daratumumab
Daratumumab is a drug used to treat Multiple Myeloma, Plasma Cell Myeloma, AL Amyloidosis, and other conditions. Daratumumab is being actively studied in 118 studies and prior, has been studied in 14.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Janssen Research & Development, LLC | Mayo Clinic | Fernando Fervenza |
| Mayo Clinic | Colorado Blood Cancer Institute | Ajai Chari |
| Celgene | Hackensack University Medical Center | Ajay Nooka |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
- Multiple Myeloma
- Daratumumab
- Cologne, GermanyUniversity of Cologne
2021-08-17
Aug 17, 2021M
Recruiting
- Lupus Nephritis
- Daratumumab
- Rochester, MinnesotaMayo Clinic in Rochester
2021-05-19
May 19, 2021W
Not yet recruiting
- Glioblastoma
- Daratumumab
- Morgantown, West VirginiaWest Virginia University Cancer Institute Mary Babb Randolph Can
2021-06-25
Jun 25, 2021A
Not yet recruiting
- Multiple Myeloma
- Lenalidomide Pill
- +2 more
- (no location specified)
2021-06-02
Jun 2, 2021A
Not yet recruiting
- Plasma Cell Leukemia
- Daratumumab
- (no location specified)
2021-09-22
Sep 22, 2021P
Recruiting
- Amyloidosis; Systemic
- Daratumumab
- +2 more
- Beijing, ChinaPeking Union Medical College Hospital
2021-05-31
May 31, 2021S
Recruiting
- Multiple Myeloma
- Daratumumab
- Charlotte, North CarolinaLevine Cancer Institute
2021-10-05
Oct 5, 2021J
Recruiting
- Chronic Lymphocytic Leukemia
- Daratumumab
- +3 more
- Columbus, OhioOhio State University Comprehensive Cancer Center
2021-09-07
Sep 7, 2021B
Completed
- AL Amyloidosis
- daratumumab
- Boston, MassachusettsBoston Medical Center
2021-04-15
Apr 15, 2021F
Completed
- Membranoproliferative Glomerulonephritis
- Daratumumab
- Rochester, MinnesotaMayo Clinic
2021-06-28
Jun 28, 2021C
Active, not recruiting
- Multiple Myeloma
- Ciforadenant
- daratumumab
- Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2021-11-01
Nov 1, 2021M
Suspended
- Plasma Cell Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
- Jacksonville, FloridaMayo Clinic in Florida
2021-09-27
Sep 27, 2021P
Recruiting
- Multiple Myeloma
- Elranatamab
- +3 more
- Hamamatsu, Shizuoka, Japan
- +9 more
2021-11-12
Nov 12, 2021R
Withdrawn
- Allosensitization
- Heart Transplant Failure and Rejection
- Daratumumab
- (no location specified)
2020-10-26
Oct 26, 2020W
Recruiting
- Multiple Myeloma
- +2 more
- Daratumumab
- +3 more
- New York, New YorkWeill Cornell Medicine - Multiple Myeloma Center
2021-11-18
Nov 18, 2021J
Approved for marketing
- Daratumumab
- (no location specified)
2020-07-03
Jul 3, 2020W
Recruiting
- Amyloid
- +2 more
- Daratumumab
- +2 more
- Palo Alto, California
- +3 more
2021-06-23
Jun 23, 2021D
Active, not recruiting
- Waldenström Macroglobulinemia
- Daratumumab
- Boston, Massachusetts
- +4 more
2021-04-21
Apr 21, 2021T
Not yet recruiting
- Newly Diagnosed Multiple Myeloma
- Daratumumab
- (no location specified)
2021-10-10
Oct 10, 2021U
Completed
- Amyloidosis
- Daratumumab
- Angers, France
- +9 more
2021-07-08
Jul 8, 2021H
Not yet recruiting
- Multiple Myeloma
- Daratumumab
- +3 more
- Hackensack, New JerseyJohn Theurer Cancer Center
2021-10-04
Oct 4, 2021M
Recruiting
- Recurrent Chronic Lymphocytic Leukemia
- +4 more
- Daratumumab
- Ibrutinib
- Jacksonville, FloridaMayo Clinic in Florida
2021-03-03
Mar 3, 2021W
Recruiting
- Waldenstrom Macroglobulinemia
- +6 more
- Ibrutinib
- Daratumumab
- New York, New YorkWeill Cornell Medicine
2020-12-22
Dec 22, 2020H
Recruiting
- Multiple Myeloma
- Selinexor 60 MG
- +6 more
- Hackensack, New JerseyJohn Theurer Cancer Center
2021-06-04
Jun 4, 2021U
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Azacitidine
- +2 more
- San Francisco, CaliforniaUniversity of California, San Francisco
2021-05-17
May 17, 2021